FDA NDC Directory · JSON-LD · Markdown

Olanzapine

NDC 0517-0955 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerAmerican Regent, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA201741
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAMUSCULAR
Active ingredientsOLANZAPINE (10 mg/2mL)
Marketing started20120627
Package count1

External sources

Source: openFDA. Public-domain (CC0).